Aperia. Prostaglandin E 2 interaction with AVP: effects on AQP2 phosphorylation and distribution. Am. J. Physiol. Renal Physiol. 278: F388-F394, 2000.-Prostaglandin E 2 (PGE 2 ) antagonizes the action of arginine vasopressin (AVP) on collecting duct water permeability. To investigate the mechanism of this antagonism, rat renal inner medulla (IM) was incubated with the two hormones, and the phosphorylation and subcellular distribution of the water channel, aquaporin-2 (AQP2) were studied. Using a phosphorylation statespecific AQP2 antibody, we demonstrated that AVP stimulates AQP2 phosphorylation at the Ser 256 protein kinase A consensus site in a time-and dose-dependent manner. In parallel studies using a differential centrifugation technique, we demonstrated that AVP induced translocation of AQP2 from an intracellular vesicle-enriched fraction to a plasma membrane-enriched fraction. PGE 2 (10 Ϫ7 M) added after AVP (10 Ϫ8 M) did not decrease AQP2 phosphorylation but reversed AVP-induced translocation of AQP2 to the plasma membrane. Preincubation of IM with PGE 2 did not prevent the effects of AVP on AQP2 phosphorylation and trafficking. PGE 2 alone did not influence AQP2 phosphorylation and subcellular distribution. Our data indicate that 1) recruitment of AQP2 to the plasma membrane and its retrieval to a pool of intracellular vesicles may be regulated independently, 2) PGE 2 may counteract AVP action by activation of AQP2 retrieval, 3) dephosphorylation of AQP2 is not a prerequisite for its internalization. inner medulla; vesicular traffic; hormonal regulation; exocytosis; endocytosis CONDITIONS OF INAPPROPRIATE water retention are not always associated with high levels of the antidiuretic hormone arginine vasopressin (AVP) (31, 35, 50) . This indicates that water excretion may be regulated by other first messengers, acting either in concert or in opposition to AVP. The identification of such factors and their mechanism of action would allow for a more specific therapy in often life-threatening conditions of water retention. Prostaglandin E 2 (PGE 2 ), which is the major cyclooxygenase product of arachidonate metabolism in collecting duct in humans, rabbits, and rats (5, 14, 51), may be one such factor. Both endogenous and exogenous prostaglandins can reverse the effect of AVP on water permeability in rat and rabbit collecting duct (27, 43, 55) . However, the mechanism(s) involved in the interaction between AVP and prostaglandins has not been well characterized.
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In the collecting duct the actions of AVP are mediated through the activation of the water channel aquaporin-2 (AQP2) (20, 21, 45, 46) . In the absence of AVP, a large fraction of AQP2 is localized to vesicles in the cytoplasm of collecting duct principal cells (46) . AVP stimulates water permeability by inducing the translocation of AQP2 to the apical membrane of the cell (41, 45, 54, 59 ), a process that appears to result from activation of protein kinase A (PKA) and phosphorylation of Ser 256 in AQP2 (19, 33, 36, 48) .
In the present study, we have examined the effect of PGE 2 on the actions of AVP in rat renal medulla. By use of a phosphorylation state-specific AQP2 antibody, it was demonstrated that PGE 2 does not reduce AVPinduced phosphorylation of AQP2 at Ser 256 . However, as demonstrated by subcellular fractionation, PGE 2 reversed the AVP-induced increase of the plasma membrane fraction of AQP2. Preincubation with PGE 2 did not prevent the effect of AVP on AQP2 phosphorylation and translocation to the plasma membrane. The results indicate that PGE 2 acts by retrieving AQP2 that has been recruited to the plasma membrane by AVP but that dephosphorylation of AQP2 is not required for this process.
METHODS

Processing of rat inner medullary tissue.
The studies were performed on male Sprague-Dawley rats (B&K Universal, Sollentura, Sweden) that were fed a standard rat chow and had free access to normal drinking water. Rats were anesthetized with thiobutabarbital (8 mg/100 g body wt), the kidneys were rapidly removed, and the inner medulla was excised and processed immediately. All studies were started between 8 and 9 AM. In some protocols, rats were treated with indomethacin (1 mg/100 g body wt; Confortid, Dumex, Copenha-
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gen, Denmark) given 16 and 1 h before the experiment to suppress the endogenous production of prostaglandins (17) . Indomethacin (10 Ϫ5 M) was added to all solutions during processing of tissue from indomethacin-treated rats.
After excision, the inner medullary tissue was kept at 30°C, since cold treatment can change the distribution of AQP2 in collecting duct cells and inhibit AVP-stimulated translocation of AQP2 to the apical membrane (6) . The inner medulla from each rat was divided into four or six equal pieces. It has been shown that the level of AQP2 gradually changes from the outer medulla to the tip of the inner medulla (34) . Therefore, dissection of the tissue was made in a radial direction from the medullary tip toward the edge that contacted the inner strip of the outer medulla. In every experiment, one portion of the dissected tissue was used as a control; the other portions of dissected tissue from the same rat were used for the various drug treatments. In tissue fractionation experiments, the tissues from two to three animals were pooled, with one piece from each animal combined in every sample.
The excised tissue was incubated at 30°C in saline solution (in mM: 137 NaCl, 5 KCl, 0. For tissue fractionation, the medulla was homogenized in buffer B (in mM: 300 sucrose, 25 imidazole, 1 EDTA, pH 7.2; containing protease inhibitors 20 µg/ml leupeptin, 20 µg/ml antipain, 5 µg/ml pepstatin A, 5 µg/ml chymostatin, and 1 mM PMSF; peptidase inhibitor 25 mM benzamidine; and protein phosphatase inhibitors 25 mM sodium fluoride, 1 mM sodium orthovanadate, and 0.1 µM okadaic acid). Fractionation was performed as described (41) using three consecutive centrifugation steps. 1) The homogenate was centrifuged at 4,000 g for 10 min, and the pellet containing nuclei and cell debris was discarded.
2) The supernatant was centrifuged at 17,000 g for 30 min. The pellet was resuspended in buffer B and considered as the plasma membrane-enriched fraction (M).
3) The supernatant from step 2 was centrifuged at 200,000 g for 1 h. The pellet was resuspended in buffer B and considered as the intracellular vesicle-enriched fraction (V). Both M and V fractions were suspended in Laemmli sample buffer, heated at 100°C for 5 min, analyzed for protein concentration using the Lowry method, and subjected to SDS-PAGE (10 µg protein/lane).
Western blotting. After electrophoresis, the proteins were transferred to Hybond-P polyvinylidene difluoride (PVDF) membrane (Amersham Sweden, Uppsala, Sweden) by electroelution. The membrane was blocked in 5% nonfat dry milk (wt/vol) in PBST (80 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 , and 100 mM NaCl, pH 7.5; Tween-20 0.1%), and AQP2 phosphorylated at Ser 256 was detected with a double affinity-purified phosphorylation state-specific rabbit antibody, AN83-2 (48). The antibody was raised against a synthetic peptide corresponding to amino acids 253-262 of rat AQP2. The peptide was chemically phosphorylated at Ser 256 , and amino acids 259 and 260 were swapped to reduce antigenicity outside the phosphorylation site. The peptide and antibody were prepared by the Rockefeller University Protein/DNA Technology Center, New York, NY, and AnaSpec, San Jose, CA. The total amount of AQP2 was evaluated using LL127 rabbit antiserum (described in Ref. 46 ) raised against a synthetic peptide corresponding to amino acids 250-271 of rat AQP2. Visualization of the proteins was performed using goat anti-rabbit horseradish peroxidase-conjugated IgG and ECL Plus Western blotting analysis system (Amersham Sweden).
After immunodetection, the PVDF membranes were stained for 5 min with amido black at room temperature and with constant shaking (amido black-10B, 0.1% wt/vol; methanol, 10% vol/vol; and acetic acid, 2% vol/vol), then three to four times for 5 min in destaining solution (methanol, 45% vol/vol; acetic acid, 7% vol/vol).
In some experiments, the PVDF membranes were consecutively probed with both AN83-2 and LL127 antibodies. After the first immunodetection, washing was performed according the manufacturer's recommendations. The PVDF membrane was incubated in stripping buffer (62.5 mM Tris · HCl, pH 6.7, 2% SDS, and 100 mM 2-mercaptoethanol) for 30 min at 50°C, then in PBST twice for 10 min at room temperature. After washing, the procedure of immunodetection was repeated using the second antibodies.
Data analysis and statistics. The X-ray films and stained PVDF membranes were scanned using a HP ScanJet 5100C and HP PrecisionScan software (Hewlett-Packard Sverige, Kista, Sweden). The images obtained were analyzed using NIH Image 1.57 software. In all cases, the antibody signal was normalized for total protein calculated from the amido black staining in each lane. The values obtained for each experimental sample were expressed as a percentage of that obtained for the corresponding control sample from the same animal. Data are presented as means Ϯ SE. Statistical analyses were made using Student's t-test. A difference of P Ͻ 0.05 was considered statistically significant.
RESULTS
AVP-dependent AQP2 phosphorylation in rat renal inner medulla.
To investigate PKA-dependent AQP2 phosphorylation in rat renal medulla and to establish the conditions necessary for the studies described below, we used the antibody that specifically recognizes AQP2 phosphorylated at Ser 256 . Both the glycosylated and nonglycosylated forms of AQP2 were partially phosphorylated at Ser 256 in control tissue (Fig. 1A) , suggesting that there is a constitutive activation of PKA in rat inner medulla. The basal AQP2 phosphorylation did not change significantly during 60 min of incubation (Fig. 1C, s) . Incubation of the tissue with AVP (10 Ϫ8 M) increased AQP2 phosphorylation at Ser 256 significantly after 1 min of incubation (Fig. 1C, r) . A maximal level was reached after 7 min and this was sustained for 30 min. After 60 min of incubation with AVP, the level of Ser 256 phosphorylation was significantly lower than after 30 min and did not differ from that observed in control samples incubated without AVP.
AVP stimulated AQP2 phosphorylation in a dosedependent manner (Fig. 1, D and F) . The level of AQP2 phosphorylation was significantly increased at 10 Ϫ10 M AVP. To check that the amount of AQP2 was the same in all samples, the filters were reprobed with an antibody that recognizes both phosphorylated and nonphosphorylated forms of AQP2 (9a). The total AQP2 abundance F389 was the same at each time point and AVP concentration (Fig. 1, B and E) .
Effect of PGE 2 on AQP2 phosphorylation in inner medullary tissue. In this series of experiments, rats were pretreated with indomethacin to suppress endogenous PG production. One part of excised inner medulla was incubated with vehicle for 30 min and another part with AVP (10 Ϫ8 M) for 30 min (Fig. 2A) . Using this protocol AVP increased AQP2 phosphorylation more than twofold (Fig. 2, B and C) . It has previously been shown that addition of 10 Ϫ7 M PGE 2 to perfused rat and rabbit collecting ducts incubated with 1-2.3 ϫ 10 Ϫ11 M AVP significantly reduced the AVPstimulated water permeability (27, 43) . Therefore, a third portion of the medulla was also incubated with AVP for 30 min, but after 15 min, PGE 2 (10 Ϫ7 M) was added. A fourth piece of the tissue from the same animal was incubated with vehicle for 15 min and then with PGE 2 (10 Ϫ7 M) for 15 min. PGE 2 did not have any effect on AQP2 Ser 256 phosphorylation (Fig. 2, B and C) . The level of AQP2 phosphorylation in samples preincubated with AVP for 15 min and then incubated with AVP and PGE 2 for 15 min was significantly higher than in vehicle-treated tissue and did not differ from that in medulla incubated with AVP alone for 30 min. PGE 2 alone did not influence the level of AQP2 Ser 256 phosphorylation in rat inner medullary tissue.
Effect of AVP and PGE 2 on AQP2 subcellular distribution in inner medulla. After incubation with hormones, inner medulla samples were fractionated using consecutive centrifugation steps to obtain a plasma membraneenriched fraction (M) and an intracellular vesicleenriched fraction (V). The adequacy of this method is well established (41, 47, 57) .
The levels of AQP2 in the M and V fractions were measured using the antibody that recognized both the phosphorylated and nonphosphorylated forms of the protein. In samples from indomethacin-treated, normally hydrated rats, ϳ60% of total AQP2 were present in the M fraction (Fig. 3A) . Incubation with AVP (10 Ϫ8 M) for 30 min caused a notable translocation of AQP2 from the V to the M fraction (Fig. 3, A and C) . AVP-induced increase in M/V ratio was significant after 5 min of incubation of rat inner medulla with AVP. It was sustained for ϳ30 min but had returned to control values after 60 min (not shown). The effect of AVP on AQP2 translocation was reversed if PGE 2 (10 Ϫ7 M) was added to the incubation medium during the last 15 min of incubation with AVP. The M/V ratio was significantly lower in AVPϩPGE 2 -treated tissue compared with AVPtreated tissue and did not differ from that of control tissue. The application of PGE 2 (10 Ϫ7 M) alone for 15 min did not change AQP2 distribution compared with control. The fraction of AQP2 that was phosphorylated was increased to the same extent in M and V fractions of tissue treated with AVP (Table 1) . It was not decreased in any fraction after PGE 2 addition to AVPtreated papillae. PGE 2 alone did not influence the state of AQP2 phosphorylation.
In the next series of experiments, renal inner medullary tissue from indomethacin-treated rats was preincubated with PGE 2 (10 Ϫ7 M) for 25 min, and then AVP (10 Ϫ8 M) was added to the incubation medium for 5 min (Fig. 4A) . Preincubation with PGE 2 did not prevent the effect of AVP on phosphorylation or distribution of AQP2. Both AQP2 phosphorylation and the AQP2 M/V ratio were significantly higher in PGE 2 ϩAVP-treated tissue compared with control tissue and did not differ from tissue treated with AVP alone for 5 min (Fig. 4, B 
and C).
DISCUSSION
It is well documented that AQP2, inserted in vesicles in the cytoplasm, will be translocated to the plasma Fig. 1 . Arginine vasopressin (AVP) stimulates aquaporin-2 (AQP2) phosphorylation in a time-and dose-dependent manner. Rat inner medullary tissue was incubated with AVP (10 Ϫ8 M) for different periods of time (A-C) or with AVP in different concentrations for 5 min (D-F). Tissue homogenates were fractionated by SDS-PAGE, transferred to Hybond-P polyvinylidene difluoride (PVDF) membranes, and AQP2 phosphorylated at Ser 256 was visualized using a phosphorylation state-specific antibody (A and D). To check that the total amount of AQP2 was the same in all samples, the PVDF membranes were reprobed using an antibody recognizing both phosphorylated and nonphosphorylated AQP2 (B and E). Antibody binding was detected by enhanced chemiluminescence and quantified using intensity measurements on the film and PVDF membrane images (C and E). Values are means Ϯ SE (n ϭ 4-7 experiments). Open circle on C represents the data obtained in samples incubated without AVP for 60 min. (41, 45, 54, 59) . In addition, studies using cells transfected with AQP2 suggest that PKA activation and phosphorylation of AQP2 are necessary for the targeting of the protein to the membrane (11, 19, 33) . The results from the present study are consistent with this hypothesis. It should be noted, however, that additional proteins, known to be important for vesicular trafficking, have been shown to be phosphorylated by PKA (14, 26) . AVP action may also involve activation of protein kinase C (PKC) (2, 54) , which phosphorylates other proteins specifically linked to regulated exocytosis (16, 18, 39) . Moreover, AVP increases intracellular calcium concentration in collecting ducts (8, 9, 13) , raising the possibility that Ca 2ϩ /calmodulin-dependent protein kinases (CaMK) could be activated. Notably, CaMKII phosphorylates a broad spectrum of components of the vesicle trafficking system (22, 28, 44, 52, 53) . Thus it is not unlikely that the targeting of the AQP2-containing vesicles to the plasma membrane is associated with a series of phosphorylation events that regulate multiple protein-protein interactions involved in the vesicle trafficking.
In the present study, the AVP concentrations necessary to stimulate phosphorylation of AQP2 were similar to those observed in water-deprived rats (32). . B: AQP2 phosphorylated at Ser 256 visualized using phosphorylation state-specific AQP2 antibody. Samples were processed as described in legend to Fig. 1 . C: quantification of antibody labeling for AQP2 phosphorylated at Ser 256 . Values are means Ϯ SE (n ϭ 9 experiments). Level of AQP2 phosphorylation is significantly increased in AVP and AVPϩPGE 2 -treated samples compared with control (P Ͻ 0.01). Fig. 3 . Effects of AVP and PGE 2 on subcellular distribution of AQP2 in rat inner medulla. A: tissue was treated as described in Fig. 2A . Plasma membrane-enriched (M) and intracellular vesicle-enriched (V) fractions obtained using differential centrifugation were subjected to SDS-PAGE and immunoblotting using AQP2 antibody recognizing both phosphorylated and nonphosphorylated form of the protein. AVP stimulated translocation of AQP2 from the M to the V fraction. PGE 2 reversed the AVP effect. B: control protein staining of the same PVDF membrane. C: quantification of AVP and PGE 2 effects. Values are means Ϯ SE (n ϭ 6 experiments). In AVP-treated samples, the ratio of AQP2 abundance in the M fraction to that in the V fraction (M/V ratio) was significantly increased compared with control (P Ͻ 0.05). In AVPϩPGE 2 -treated tissue the M/V ratio was significantly lower than in AVP-treated samples (P Ͻ 0.05) and did not differ from the control value. Values are means Ϯ SE; n ϭ 5 experiments. Ratio of phosphorylated aquaporin-2 (AQP2) to total AQP2 abundance in every sample is expressed in percent of that in control sample from the same rat. AVP, arginine vasopressin. Tissue samples were treated according to protocol described in Fig. 2A . * Ratio of phosphorylated AQP2 to total AQP2 abundance is significantly higher than in control.
However, both the time course and the effective AVP level might be underestimated in our experiments, since AVP had to penetrate several cellular layers to reach the entire volume of tissue. The AVP-induced phosphorylation of AQP2 was rapid and lasted for ϳ30 min, but between 30 and 60 min significant dephosphorylation occurred. This effect may be attributed to a gradual degradation of AVP in incubation medium and to the action of protein phosphatases, which are abundantly expressed in rat inner medulla (7, 38, 58) . The progressive loss of AQP2 32 P labeling following exogenous PKA-stimulated AQP2 phosphorylation has been previously observed in rat papillary water channelcontaining vesicle preparations (37) . The presence of protein phosphatase 2B (PP2B or calcineurin), as well as type II regulatory subunit of PKA and -isoform of protein kinase C (PKC-), has been recently demonstrated in AQP2-bearing vesicles (29) . The colocalization of protein kinases, protein phosphatases, and AQP2 could provide operative and precise regulation of the state of phosphorylation of this water channel.
In our experiments, AVP-induced redistribution of AQP2 was significant starting from 5 min up to 30 min of incubation of the tissue with the hormone. By 60 min of the incubation, AQP2 distribution returned to that in control tissue, probably due to AVP stimulation exhaustion. In a parallel study performed in Wistar and Brattleboro rats (9a) we have shown that in vivo the AQP2 redistribution effect of more degradation-resistant vasopressin analog 1-desamino-8-D-arginine vasopressin (dDAVP) lasted up to 2 h. By that time there was no increase in total amount of phosphorylated AQP2, suggesting a hypothesis that sustained phosphorylation may not be required for AQP2 to stay in the apical membrane.
In these studies, PGE 2 alone did not have any effect on AQP2 phosphorylation or on its subcellular distribution. These results agree with other studies in rat collecting duct where PGE 2 has no effect on cAMP production (40) or on water permeability (41), in contrast to the situation in rabbits (3, 25, 43) . However, in these studies, PGE 2 stimulated the retrieval of AQP2 from the plasma membrane in AVP-stimulated tissue. Theoretically, PGE 2 might have interrupted an AVPinduced continuous supply of AQP2 to the plasma membrane or stimulate endocytosis of AQP2. The finding that preincubation with PGE 2 did not prevent AVP-stimulated recruitment of AQP2 to the plasma membrane tends to support the latter possibility.
The cellular mechanism by which PGE 2 may regulate retrieval of AQP2 from the membrane remains to be elucidated. In collecting duct, PGE 2 may interact with several types of PG receptors, including EP1, EP2, EP3, and EP4 (23, 24, 27, 49) . These receptors can activate a variety of signaling pathways including activation (EP2 and EP4) and inhibition (EP3) of adenylyl cyclase and activation of phospholipase C (EP1). Both EP1 and EP3 prostaglandin receptors might participate in the PGE 2 -induced endocytosis of AQP2 observed in our studies. Our results indicate that dephosphorylation of AQP2 is not a prerequisite for its retrieval from the plasma membrane. It is not excluded, however, that an EP3-mediated decrease in intracellular cAMP level may lead to PGE 2 -induced redistribution of AQP2 via dephosphorylation of other proteins involved in vesicle trafficking. On the other hand, it is known that pretreatment with pertussis toxin does not prevent the ability of PGE 2 to reverse the effects of AVP (1, 49) . There is also clear evidence for role of PKC (4, 23, 41, 47) and Ca 2ϩ (1, 26) in mediating the PGE 2 action.
We suggest that the distribution of AQP2 in rat inner medulla is regulated by a balance between AVP and PGE 2 . Decrease in PGE 2 production by cyclooxygenase inhibitors would lead to a reduction of AQP2 endocyto- sis and therefore to increased abundance of AQP2 in the plasma membrane. This hypothesis is in a good agreement with observations that 2 days of indomethacin or diclofenac treatment induces a striking shift of AQP2 from intracellular vesicle-enriched fraction to the plasma membrane-enriched fraction of rat inner medulla (14) .
The finding that PGE 2 reverses the AVP-induced redistribution of AQP2 to the plasma membrane, may have important pathophysiological implications. Indomethacin therapy to suppress endogenous PG production is widely used to close patent ductus arteriosus in infants, and water retention is not an uncommon complication of this therapy (10, 30) . Notably, PGE 2 counteracts the effect of AVP on water permeability in the collecting duct in several species, including rabbit and rat (27, 43, 55) , and clearance studies suggest that such a bidirectional regulation of water permeability by AVP and PGE 2 also exists in man (12) .
